Peter Sprinz
PhD, Research Scientist,
Manufacturing Science & Technology—Statistics
Eli Lilly and Company
|
 Add this Podcast feed to your media player
Using Stability Models to Predict Drug Characteristics at the End of Shelf Life
Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Listen to hear how Lilly has implemented such models, and what they have gained by doing so.
Related Links
Characterizing the Formulation Design Space
Best Practices for Formulation and Manufacturing of Biotech Drug Products
Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients
Click here to go to the main podcast page >>>
|
